Drug Manufacturers Promise $80 Billion In Rx Savings—But How Much Are They Saving Themselves?
Posted on July 2nd, 2009 by ICR Bloggers in From Insurance Company Rules
 |
Drug manufacturers are not acting out of a charitable impulse. They are trying to forestall strong health reform legislation that would cost the industry more than it is promising. PhRMA took action in 2003 when adding a drug benefit to Medicare seemed inevitable and managed to keep a public health insurance plan—Medicare—from cutting drug costs. Now the threat of a new public health insurance option for people under 65 has spurred the powerful lobby into action once more, with promises of cooperation and voluntary discounts. Don’t be fooled! We can do better.
No comments yet.